UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 423

Sortiert nach

All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study

Clinical infectious diseases, 2021-06, Vol.72 (12), p.2079-2086

2021

Volltextzugriff (PDF)

Broad synergistic antiviral efficacy between a novel elite controller-derived dipeptide and antiretrovirals against drug-resistant HIV-1

Frontiers in cellular and infection microbiology, 2024-06, Vol.14, p.1334126

2024

Volltextzugriff (PDF)

Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy

Frontiers in microbiology, 2021-06, Vol.12, p.667718-667718

2021

Volltextzugriff (PDF)

Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase

Pharmaceuticals (Basel, Switzerland), 2019-04, Vol.12 (2), p.62

2019

Volltextzugriff (PDF)

Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1

Bioinformatics (Oxford, England), 2024-06, Vol.40 (6)

2024

Volltextzugriff (PDF)

Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells

PLoS pathogens, 2020-01, Vol.16 (1), p.e1008264-e1008264

2020

Volltextzugriff (PDF)

Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia

PloS one, 2018-07, Vol.13 (7), p.e0200505-e0200505

2018

Volltextzugriff (PDF)

Synergistic antiviral activity against drug-resistant HIV-1 by naturally occurring dipeptide and A single-stranded oligonucleotide

Drug resistance updates, 2023-05, Vol.68, p.100955-100955, Article 100955

2023

Volltextzugriff (PDF)

HIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gaps

PloS one, 2013-08, Vol.8 (8), p.e72257-e72257

2013

Volltextzugriff (PDF)

Infectivity of SARS-CoV-2: there Is Something More than D614G?

Journal of neuroimmune pharmacology, 2020-12, Vol.15 (4), p.574-577

2020

Volltextzugriff (PDF)

Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIV

Journal of internal medicine, 2023-04, Vol.293 (4), p.445-456

2023

Volltextzugriff (PDF)

Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution

Frontiers in microbiology, 2018-10, Vol.9, p.2358-2358

2018

Volltextzugriff (PDF)

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine

ACS infectious diseases, 2021-05, Vol.7 (5), p.1104-1115

2021

Volltextzugriff (PDF)

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents

Expert opinion on therapeutic patents, 2021-04, Vol.31 (4), p.339-350

2021

Volltextzugriff (PDF)

HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness

Journal of virology, 2019-05, Vol.93 (9)

2019

Volltextzugriff (PDF)

Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes

AIDS (London), 2018-02, Vol.32 (4), p.469-476

2018

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells

Frontiers in immunology, 2018-01, Vol.9, p.19-19

2018

Volltextzugriff (PDF)

Prophylaxis and treatment of HIV infection in pregnancy, Swedish guidelines 2024

Infectious diseases (London, England), 2024-08, Vol.56 (8), p.1-668

2024

Volltextzugriff (PDF)

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels

BMC infectious diseases, 2016-06, Vol.16 (1), p.305-305, Article 305

2016

Volltextzugriff (PDF)

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz

Pharmacogenetics and genomics, 2006-03, Vol.16 (3), p.191-198

2006

Volltextzugriff (PDF)

Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study

PloS one, 2016-09, Vol.11 (9), p.e0162503-e0162503

2016

Volltextzugriff (PDF)

Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades

PloS one, 2014-06, Vol.9 (6), p.e99390-e99390

2014

Volltextzugriff (PDF)

Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden

The lancet HIV, 2016-04, Vol.3 (4), p.e166-e174

2016

Volltextzugriff (PDF)

Prediction of coreceptor usage by five bioinformatics tools in a large Ethiopian HIV-1 subtype C cohort

PloS one, 2017-08, Vol.12 (8), p.e0182384-e0182384

2017

Volltextzugriff (PDF)

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations

International journal of antimicrobial agents, 2018-05, Vol.51 (5), p.733-738

2018

Volltextzugriff (PDF)

1 – 25 von 423

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(389)
Mit Volltextzugriff
(398)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study

Broad synergistic antiviral efficacy between a novel elite controller-derived dipeptide and antiretrovirals against drug-resistant HIV-1

Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy

Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase

Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1

Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells

Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia

Synergistic antiviral activity against drug-resistant HIV-1 by naturally occurring dipeptide and A single-stranded oligonucleotide

HIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gaps

Infectivity of SARS-CoV-2: there Is Something More than D614G?

Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIV

Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents

HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness

Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes

Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells

Prophylaxis and treatment of HIV infection in pregnancy, Swedish guidelines 2024

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz

Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study

Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades

Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden

Prediction of coreceptor usage by five bioinformatics tools in a large Ethiopian HIV-1 subtype C cohort

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations

Suchergebnisse filtern